For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...
Cancer imaging company Kuva Labs is expanding its scope via the acquisition of solid tumor biotech Lisata Therapeutics.
Scientists at the Ecole Polytechnique Fédérale de Lausanne (EPFL) have addressed a long-standing challenge in the pharmaceutical industry, with the development of a two-step, one-pot method for ...
FUJIFILM Corporation announces the successful validation of the cancer cell-targeting potential of its peptide-oligonucleotide conjugates. This validation resulted from combining oligonucleotides with ...
BEIJING, Jan. 8, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically ...
The farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism. Bile acids are natural ligands of FXR, which bind to the ...
Peptide therapeutics have revolutionized the treatment of disease, but their characteristics typically restrict them to administration by injection. Now, researchers have succeeded in creating an oral ...
The farnesoid X receptor (FXR) is a bile acid nuclear receptor that plays a crucial role in regulating bile acid and sterol metabolism. Bile acids are natural ligands of FXR, which bind to the ...
Morning Overview on MSN
Plants hijack bacterial-style gene to make drugs, opening green pharma future
Plants are quietly borrowing tricks from bacteria, repurposing foreign genes to build complex molecules that look a lot like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results